| Literature DB >> 32076388 |
Theodore Bowe1,2, Lily Nyamai3, Dupe Ademola-Popoola4, Atchara Amphornphruet5, Rachelle Anzures6, Linda A Cernichiaro-Espinosa7, Roseline Duke8, Fahir Duran9, Maria Ana Martinez-Castellanos6, Prabhujot Kaur Multani10, Cristina E Nitulescu11, Tapas Ranjan Padhi10, Boontip Tipsuriyaporn1,2,12, R V Paul Chan13, J Peter Campbell14, Yoshihiro Yonekawa15.
Abstract
Retinopathy of prematurity (ROP) is one of the leading causes of preventable blindness in children worldwide. Middle-income nations are currently experiencing epidemic levels of ROP, because greater access to neonatal intensive care units has improved survival rates of premature infants, but without sophisticated oxygen regulation. The epidemiology, screening infrastructure, treatment options, and challenges that these countries face are often tied to unique local socioeconomic, cultural, geopolitical, and medical factors. We present an overview and narratives of the current state of ROP in eight countries that are or soon will be experiencing ROP epidemics-India, Kenya, Mexico, Nigeria, Phillipines, Romania, Thailand, and Venezuela-with a view to fostering both an understanding of the differences in the ROP landscape in various settings and an interest in the further development of ROP screening and treatment services tailored to local requirements.Entities:
Mesh:
Year: 2019 PMID: 32076388 PMCID: PMC7001648 DOI: 10.5693/djo.01.2019.08.002
Source DB: PubMed Journal: Digit J Ophthalmol ISSN: 1542-8958